Prognostic value of breast cancer aromatase

Allan Lipton, Richard J. Santen, Steven J. Santner, Harold A. Harvey, Sherry I. Sanders, Yvonne L. Matthews

Research output: Contribution to journalArticle

70 Scopus citations

Abstract

The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.

Original languageEnglish (US)
Pages (from-to)1951-1955
Number of pages5
JournalCancer
Volume70
Issue number7
DOIs
StatePublished - Oct 1 1992

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Prognostic value of breast cancer aromatase'. Together they form a unique fingerprint.

  • Cite this

    Lipton, A., Santen, R. J., Santner, S. J., Harvey, H. A., Sanders, S. I., & Matthews, Y. L. (1992). Prognostic value of breast cancer aromatase. Cancer, 70(7), 1951-1955. https://doi.org/10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#